Slide Background

Lydia Krabbendam

Professor Developmental Neuropsychology
Faculteit der gedrags- en bewegingswetenschappen

Samen met mijn groep onderzoek ik de ontwikkeling van hogere cognitieve functies (executieve functies, metacognitie, sociale cognitie) en de relatie met schools functioneren, welbevinden en probleemgedragtijdens de adolescentie.

Slide Background

Lydia Krabbendam

Professor Developmental Neuropsychology
Faculteit der gedrags- en bewegingswetenschappen

Samen met mijn groep onderzoek ik de ontwikkeling van hogere cognitieve functies (executieve functies, metacognitie, sociale cognitie) en de relatie met schools functioneren, welbevinden en probleemgedragtijdens de adolescentie.

2011

Arts, B., Jabben, N., Krabbendam, L. & Os, J. van (2011). A 2-year naturalistic study on cognitive functioning in bipolar disorder. Acta Psychiatr Scand, 123(3),190-205. IF 3.733

Boyette, L., Swets, M., Meijer, C., Wouters, L. & GROUP Investigators (2011). Factor structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive-compulsive symptoms. Psychiatry Res, 30, 186(2-3):409-13. IF 2.373

Chen, X., Lee, G., Maher, B.S., Fanous, A.H., Chen, J., Zhao, Z., Guo, A., Oord, E. van den, Sullivan, P.F., Shi, J., Levinson, D.F., Gejman, P.V., Sanders, A., Duan, J., Owen, M.J., Craddock, N.J., O’Donovan, M.C., Blackman, J., Lewis, D., Kirov, G.K., Qin, W., Schwab, S., Wildenauer, D., Chowdari, K., Nimgaonkar, V., Straub, R.E., Weinberger, D.R., O’Neill, F.A., Walsh, D., Bronstein, M., Darvasi, A., Lencz, T., Malhotra, A.K., Rujescu, D., Giegling, I., Werge, T., Hansen, T., Ingason, A., Noethen, M.M., Rietschel, M., Cichon, S., Djurovic, S., Andreassen, O.A., Cantor, R.M., Ophoff, R., Corvin, A., Morris, D.W., Gill, M., Pato, C.N., Pato, M.T., Macedo, A., Gurling, H.M., McQuillin, A., Pimm, J., Hultman, C., Lichtenstein, P., Sklar, P., Purcell, S.M., Scolnick, E., St Clair, D., Blackwood, D.H., Kendler, K.S. & GROUP investigators (2011). GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Molecular Psychiatry, 16(11):1117-29. IF 15.049

Fett, A.J., Viechtbauer, W., Dominguez Mde G, Os, J. van & Krabbendam, L. (2011). The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis. Neurosci Biobehavi Rev, 35:573-88. IF 7.791

Gromann, P.M., Goossens, F. & Krabbendam, L. (2011). Comments on ‘Bullying victimization in youths and mental health problems: much ado about nothing?’ Psychol Med, 41(10), 2236-2237.

GROUP Investigators (2011). Evidence That Familial Liability for Psychosis Is Expressed as Differential Sensitivity to Cannabis: An Analysis of Patient-Sibling and Sibling-Control Pairs. Arch Gen Psychiatry, 68: 138 – 147. IF 12.257

Ingason, A., Rujescu, D., Cichon, S., Sigurdsson, E., Sigmundsson, T., Pietilainen, O.P., Buizer-Voskamp, J.E., Strengman, E., Francks, C., Muglia, P., Gylfason, A., Gustafsson, O., Olason, P.I., Steinberg, S., Hansen, T., Jakobsen, K.D., Rasmussen, H.B., Giegling, I., Moller, H.J., Hartmann, A., Crombie, C., Fraser, G., Walker, N., Lonnqvist, J., Suvisaari, J., Tuulio-Henriksson, A., Bramon, E., Kiemeney, L.A., Franke, B., Murray, R., Vassos, E., Toulopoulou, T., Muhleisen, T.W., Tosato, S., Ruggeri, M., Djurovic, S., Andreassen, O.A., Zhang, Z., Werge, T., Ophoff, R.A., GROUP Investigators, Rietschel, M., Nothen, M.M., Petursson, H., Stefansson, H., Peltonen, L., Collier, D., Stefansson, K. & Clair, D.M. (2011). Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry, 16, 17-25. IF 15.049

Quee, P.J., Meer, L. van der, Bruggeman, R., Haan, L. de, Krabbendam, L., Cahn, W., et al.(2011). Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness. Schizophr Bull, 37(1), 29-37.

Simons, C., Sambeth, A., Krabbendam, L., Pfeifer, S., Os, J. van & Riedel, W.J. (2011). Auditory P300 and N100 components as intermediate phenotypes for psychotic disorder: familial liability and reliability. Clin Neurophysiol, 122, 1984-1990. IF 3.122

Smee, C., Krabbendam, L.,O’Daly, O., Prins, A.M., Nalesnik, N., Morley, L., Samson, G. & Shergill, S. (2011).An fMRI study of prefrontal dysfunction and symptomatic recovery in schizophrenia. Acta Psychiatr Scand, 123(6):440-50. IF 3.733

Steinberg, S., Mors, O., Borglum, A.D., Gustafsson, O., Werge, T., Mortensen, P.B., Andreassen, O.A., Sigurdsson, E., Thorgeirsson, T.E., Bottcher, Y., Olason, P., Ophoff, R.A., Cichon, S., Gudjonsdottir, I.H., Pietilainen, O.P., Nyegaard, M., Tuulio-Henriksson, A., Ingason, A., Hansen, T., Athanasiu, L., Suvisaari, J., Lonnqvist, J., Paunio, T., Hartmann, A., Jurgens, G., Nordentoft, M., Hougaard, D., Norgaard-Pedersen, B., Breuer, R., Moller, H.J., Giegling, I., Glenthoj, B., Rasmussen, H.B., Mattheisen, M., Bitter, I., Rethelyi, J.M., Sigmundsson, T., Fossdal, R., Thorsteinsdottir, U., Ruggeri, M., Tosato, S., Strengman, E., GROUP Investigators, Kiemeney, L.A., Melle, I., Djurovic, S., Abramova, L., Kaleda, V., Walshe, M., Bramon, E., Vassos, E., Li, T., Fraser, G., Walker, N., Toulopoulou, T., Yoon, J., Freimer, N.B., Cantor, R.M., Murray, R., Kong, A., Golimbet, V., Jonsson, E.G., Terenius, L., Agartz, I., Petursson, H., Nothen, M.M., Rietschel, M., Peltonen, L., Rujescu, D., Collier, D.A., Stefansson, H., St Clair, D. & Stefansson, K. (2011). Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry, 16, 59-66. IF 15.049

Dael, F. van, Os, J. van, Graaf, R. de, Have, M. ten, Krabbendam, L., Myin-Germeys, I. (2011). Can obsessions drive you mad? Longitudinal evidence that obsessive-compulsive symptoms worsen the outcome of early psychotic experiences. Acta Psychiatr Scand, 123, 136-46. IF 3.733

Winkel, R. van, GROUP Investigators (2011). Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of Cannabis: Sibling Analysis and Proband Follow-up. Arch Gen Psychiatry, 68(2):148-57. IF 12.257

Winkel, R. van, Beveren, N.J. van, Simons, C., Kahn, R.S., Linszen, D.H., Os, J. van, Wiersma, D., Bruggeman, R., Cahn, W., Haan, L. de, Krabbendam, L. & Myin-Germey,s I. (2011). AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder. Neuropsychopharmacology, 36, 2529-37.

Williams, H.J., Norton, N., Dwyer, S., Moskvina, V., Nikolov, I., Carroll, L., Georgieva, L., Williams, N.M., Morris, D.W., Quinn, E.M., Giegling, I., Ikeda, M., Wood, J., Lencz, T., Hultman, C., Lichtenstein, P., Thiselton, D., Maher, B.S., International Schizophrenia Consortium, GROUP Investigators, Malhotra, A.K., Riley, B., Kendler, K.S., Gill, M., Sullivan, P., Sklar, P., Purcell, S., Nimgaonkar, V.L., Kirov, G., Holmans, P., Corvin, A., Rujescu, D., Craddock, N. (2011). Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry,16(4):429-41. IF 15.049